Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quantum Healthcare Ltd. (SG:V8Y)
SGX:V8Y
Quantum Healthcare Ltd. (V8Y) Share Price & Analysis
0 Followers
V8Y Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Quantum Healthcare Ltd. News
PremiumCompany Announcements
Quantum Healthcare Ltd.’s Smooth AGM
PremiumCompany Announcements
Quantum Healthcare Announces New Office Location
PremiumCompany Announcements
Quantum Healthcare Reports FY2023 Financial Struggles
PremiumCompany Announcements
Quantum Healthcare Holds Successful EGMV8Y FAQ
What was Quantum Healthcare Ltd.’s price range in the past 12 months?
Currently, no data Available
What is Quantum Healthcare Ltd.’s market cap?
Currently, no data Available
When is Quantum Healthcare Ltd.’s upcoming earnings report date?
Quantum Healthcare Ltd.’s upcoming earnings report date is Feb 29, 2024 which is 79 days ago.
How were Quantum Healthcare Ltd.’s earnings last quarter?
Currently, no data Available
Is Quantum Healthcare Ltd. overvalued?
According to Wall Street analysts Quantum Healthcare Ltd.’s price is currently same.
Does Quantum Healthcare Ltd. pay dividends?
Quantum Healthcare Ltd. does not currently pay dividends.
What is Quantum Healthcare Ltd.’s EPS estimate?
Quantum Healthcare Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Quantum Healthcare Ltd. have?
Quantum Healthcare Ltd. has 8,014,501,000 shares outstanding.
What happened to Quantum Healthcare Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Quantum Healthcare Ltd.?
Currently, no hedge funds are holding shares in SG:V8Y
---
Quantum Healthcare Ltd. Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Company Description
Quantum Healthcare Ltd.
Quantum Healthcare Ltd formerly QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular diseases. It designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The firm offers coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma; and Glider PTCA for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for the treatment of blocked arteries; GliderfleX PTA for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature.
---
---